UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000007834
Receipt No. R000008819
Scientific Title A randomized phase III study of oxaliplatin based chemotherapy versus combination chemotherapy of TS-1,irinotecan and bevacizumab as first line therapy for unresectable or recurrent colorectal cancer
Date of disclosure of the study information 2012/05/11
Last modified on 2019/01/07 16:58:31

No. Disposal Last modified on Item of update
1 Insert 2012/04/25 09:17:59
2 Update 2012/04/25 10:19:33 Name of person sending information
Name of person sending information
Email
3 Update 2012/04/26 11:02:00 Date of disclosure of the study information
4 Update 2012/05/07 09:38:57 Date of disclosure of the study information
5 Update 2012/09/13 09:10:06 Recruitment status
6 Update 2013/04/25 09:07:51 Name of person sending information
Name of person sending information
Division name
Division name
Email
7 Update 2014/01/15 10:40:05 TEL
Email
Last name of contact person
Last name of contact person
TEL
Email
8 Update 2014/10/22 13:42:57 Recruitment status
9 Update 2015/02/04 09:20:17 Email1
10 Update 2015/04/02 13:38:16 Last name of lead principal investigator
Organization
Organization
11 Update 2015/04/03 09:20:34 Last name of lead principal investigator
Division name
Division name
Address
Address
12 Update 2017/07/06 10:51:05 Organization
Name of primary sponsor
Organization
13 Update 2017/07/06 10:54:23 Address
Address
14 Update 2017/07/06 10:55:34 Address
15 Update 2017/11/01 10:54:54 Division name
Division name
16 Update 2018/02/21 10:49:11 Publication of results
URL related to results and publications
17 Update 2019/01/07 16:58:31 Recruitment status
Date analysis concluded


Contact us.